| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 03/14/2013 | US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 03/13/2013 | CN102971286A New cathepsin S protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions |
| 03/13/2013 | CN102964269A Novel preparation method of iopromide |
| 03/13/2013 | CN102964239A Metallo-beta-lactamase inhibitor |
| 03/13/2013 | CN102050720B Novel DHA derivative and its usage as medicine |
| 03/12/2013 | CA2558051C Palladium catalyzed indolization of 2-bromo or chloroanilines |
| 03/07/2013 | WO2013030654A1 Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof |
| 03/07/2013 | WO2013030358A1 Glycine b antagonists |
| 03/07/2013 | US20130059914 Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof |
| 03/07/2013 | CA2847285A1 Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof |
| 03/06/2013 | EP2563355A1 Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers |
| 03/06/2013 | CN102952035A New tigecycline crystal form and preparation method thereof |
| 03/06/2013 | CN102952029A Reagent and method for resolving 2-hydroxyl-3-methoxy-3,3-diphenyl propionic acid racemate |
| 03/06/2013 | CN102417593B Biodegradable water treatment agent asparamido polyepoxy succinic acid and preparation method thereof |
| 03/05/2013 | US8389768 Methods and compositions comprising novel cationic lipids |
| 03/05/2013 | US8389765 Purification of iodixanol |
| 02/28/2013 | WO2013026942A1 Tubulin binding agents |
| 02/28/2013 | US20130053543 Peptide clearing agents |
| 02/28/2013 | US20130053490 Wax and method for producing same |
| 02/28/2013 | US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/27/2013 | EP2562154A1 Method for preparing combretastatin |
| 02/27/2013 | EP2560947A1 Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | EP2560486A1 Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof |
| 02/27/2013 | CN102947265A Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | CN102942477A Octenoic acid derivatives and preparation method thereof |
| 02/27/2013 | CN102940891A Lipids, lipid complexes and use thereof |
| 02/27/2013 | CN101346336B 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 02/26/2013 | US8383610 Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline |
| 02/26/2013 | CA2522636C Process for the preparation of highly concentrated flowable aqueous solutions of betaines |
| 02/21/2013 | WO2013024383A1 An improved process for the preparation of lacosamide |
| 02/21/2013 | WO2012170952A9 Compounds for targeting drug delivery and enhancing sirna activity |
| 02/20/2013 | CN102936207A New synthesis method of important biochemical reagent L-leucine-4-nitroaniline hydrochloride |
| 02/19/2013 | US8377990 Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013021309A1 Intermediate and process for the preparation of a sulfonamide derivative |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | CN102933554A Crosslinking reagents, methods, and compositions for studying protein-protein interactions |
| 02/13/2013 | CN102924567A Peptide compound and preparation method and use of peptide compound |
| 02/13/2013 | CN102924322A Novel crystal form of tigecycline and preparation method thereof |
| 02/13/2013 | CN102924321A Method for extracting glutamine from fermentation liquor |
| 02/13/2013 | CN101979376B Method for preparing glycinamide hydrochloride |
| 02/13/2013 | CN101445469B Inhibitors of histone deacetylase |
| 02/13/2013 | CN101282940B Fluorinated compounds |
| 02/12/2013 | US8372995 For parental administration |
| 02/07/2013 | US20130035351 Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035328 Antiviral compounds and methods |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/07/2013 | US20130035284 Small-molecule inhibitors of dengue and west nile virus proteases |
| 02/07/2013 | DE102011109187A1 Conjugation agent useful e.g. for bioassay and in medical diagnosis, comprises protected Staudinger component that is convertible into unprotected Staudinger component before conjugation reaction, and is linked with carrier by spacer group |
| 02/06/2013 | CN102911077A Method for preparing 4R-tigecycline |
| 02/06/2013 | CN102908634A Double-strand quaternary ammonium type nuclear magnetic resonance imaging contrast agent and preparation method thereof |
| 02/06/2013 | CN101538223B Preparation method for N-(2-phenyl)ethyl-2-[(2,2-dimethoxyethyl)amino]acetamide halate |
| 02/05/2013 | US8367677 Non-glycosylated/non-glycosidic/non-peptidic small molecule PSGL-1 mimetics for the treatment of inflammatory disorders |
| 02/05/2013 | CA2492273C 3, 10, and 12a substituted tetracycline compounds |
| 01/31/2013 | WO2013014354A1 Novel ceramide analogues, processes for preparing same and uses thereof |
| 01/31/2013 | WO2013014191A1 Chemical process for opening ring compounds |
| 01/31/2013 | WO2013013504A1 Tigecycline derivative |
| 01/31/2013 | WO2012001710A8 An improved process for the preparation of lacosamide |
| 01/31/2013 | US20130030359 Dipeptide-based prodrug linkers for aromatic amine-containing drugs |
| 01/31/2013 | US20130030216 Process for the preparation of lacosamide |
| 01/31/2013 | US20130030195 Crystalline Minocycline Base and Processes for its Preparation |
| 01/31/2013 | US20130029943 Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries |
| 01/31/2013 | US20130029930 Activation and activators of sirt6 |
| 01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 01/31/2013 | US20130028540 Epoxy resin curing agent, epoxy resin composition, and adhesive agent for lamlinate |
| 01/31/2013 | CA2842390A1 Chemical process for opening ring compounds |
| 01/30/2013 | EP2551260A1 Chemical process for opening ring compounds |
| 01/30/2013 | CN102906076A Combretastatin derivative preparation method |
| 01/30/2013 | CN102898326A Preparation method of chlortetracycline hydrochloride |
| 01/30/2013 | CN102898325A Tigecycline crystal and preparation method thereof |
| 01/30/2013 | CN102898324A Method for preparing (S)-2-aminobutanamide hydrochloride |
| 01/24/2013 | WO2013011526A1 Process for preparation of lisdexamphetamine and salts thereof |
| 01/24/2013 | US20130023644 Beta-amino acids |
| 01/24/2013 | US20130022647 Polymers for reversing heparin-based anticoagulation |
| 01/24/2013 | US20130022553 Novel polyamino polyketide antibiotics and uses thereof |
| 01/23/2013 | CN102887833A Iodine-containing dimer contrast medium |
| 01/23/2013 | CN102382007B Doxycycline hydrochloride compound and preparation method thereof |
| 01/23/2013 | CN101811978B Preparation method of 2-aminobutanamide hydrochloride |
| 01/22/2013 | US8357722 Lipids, lipid complexes and use thereof |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | WO2013007725A2 Aliskiren hemifumarate, crystal form and amorphous solid |
| 01/17/2013 | WO2012129452A3 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
| 01/17/2013 | US20130018159 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 01/16/2013 | EP2546243A1 Method for preparing aliskiren and intermediate thereof |
| 01/16/2013 | CN102875411A Method for separating and purifying iodixanol injection raw materials by macroporous resin |
| 01/16/2013 | CN102219744B Preparation method of telmisartan intermediate and intermediate compound |
| 01/16/2013 | CN101684078B Chemical synthesis method for of 2-amino-butanamide hydrochloride |
| 01/15/2013 | CA2706833C Geranyl compounds |
| 01/15/2013 | CA2706826C Geranyl compounds |
| 01/10/2013 | WO2013005045A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/10/2013 | US20130012611 Synergists |
| 01/10/2013 | US20130012502 Pharmaceutical or Veterinary Antiviral Compositions |
| 01/10/2013 | US20130012480 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same |
| 01/10/2013 | US20130012466 Colchicine neoglycosides and methods for their synthesis and use |
| 01/10/2013 | US20130011465 Composition and method for the treatment of diseases affected by apoptosis |
| 01/10/2013 | CA2841042A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/09/2013 | EP2543659A1 Dendrimers as non-viral vehicles for gene therapy |
| 01/09/2013 | CN102863354A Method for dynamically splitting 2-amino-butyrylamide |